Nitric oxide (NO) as a cellular signaling molecule and vasodilator regulates a range of physiological and pathological processes. Nitrite (NO2−) is recycled in vivo to generate nitric oxide, particularly in physiologic hypoxia and ischemia. The cytochrome c oxidase (CcO) binuclear hemea3/CuB active site is one entity known to be responsible for cellular nitrite conversion to nitric oxide. We recently reported that a partially reduced heme/Cu assembly reduces nitrite ion, producing NO; the heme serves as the reductant and cupric ion provides a Lewis Acid interaction with nitrite, facilitating nitrite (N−O) bond cleavage (Hematian et al., J Am Chem Soc 134:18912–18915, 2012). To further investigate this nitrite reductase (NIR) chemistry, copper(II)-nitrito complexes with tri-and tetra-dentate ligands were used in this study, where either O,O'-bidentate or O-unidentate modes of nitrite binding to the cupric center are present. To study the role of the reducing ability of the ferrous heme center, two different tetraarylporphyrinate-iron(II) complexes, one with electron donating para-methoxy peripheral substituents, (TMPP)FeII, and the other with electron withdrawing 2,6-difluorophenyl substituents, (F8)FeII, were employed. The results show that differing nitrite coordination modes to copper(II) ion leads to varying kinetic behavior. Here, also, the ferrous heme is in all cases the source of the reducing equivalent required to take nitrite to nitric oxide, but the reduction ability of the heme center does not play a key role in the observed overall reaction rate. Based on our observations, reaction mechanisms are proposed and discussed in terms of heme/Cu heterobinuclear structures.